We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSYS icon
1426
Stratasys
SSYS
$767M
-819
Closed -$9K
STIM icon
1427
Neuronetics
STIM
$223M
-3,000
Closed -$8K
STZ icon
1428
Constellation Brands
STZ
$22.9B
-273
Closed -$36K
STZ icon
1429
PUT
Constellation Brands
STZ
$22.9B
-15
Closed -$2K
SWK icon
1430
CALL
Stanley Black & Decker
SWK
$15.5B
-21
Closed -$1K
SWK icon
1431
Stanley Black & Decker
SWK
$15.5B
-546
Closed -$40K
SYBT icon
1432
Stock Yards Bancorp
SYBT
$2.64B
-100
Closed -$6K
SYM icon
1433
Symbotic
SYM
$5.35B
-14
Closed
SYY icon
1434
Sysco
SYY
$40.5B
-14
Closed -$1K
TALK icon
1435
Talkspace
TALK
$869M
-2,000
Closed -$5K
TDOC icon
1436
CALL
Teladoc Health
TDOC
$1.22B
-272
Closed -$2K
TDOC icon
1437
Teladoc Health
TDOC
$1.22B
-7,624
Closed -$58K
TDS icon
1438
Telephone and Data Systems
TDS
$3.82B
-34
Closed -$1K
TEAM icon
1439
Atlassian
TEAM
$39.4B
-97
Closed -$15K
TEL icon
1440
CALL
TE Connectivity
TEL
$62B
-10
Closed -$2K
TEL icon
1441
TE Connectivity
TEL
$62B
-14
Closed -$3K
TEVA icon
1442
Teva Pharmaceuticals
TEVA
$42.8B
-21,908
Closed -$442K
TGB
1443
Trekor Metals
TGB
$3.2B
-14
Closed
TGT icon
1444
Target
TGT
$69.9B
-5,650
Closed -$506K
TGTX icon
1445
TG Therapeutics
TGTX
$7.58B
-409
Closed -$14K
TMDX icon
1446
Transmedics
TMDX
$3.02B
-305
Closed -$34K
TMO icon
1447
Thermo Fisher Scientific
TMO
$223B
-475
Closed -$230K
TNA icon
1448
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.49B
-30,000
Closed -$1.36M
STLN
1449
Starling Oncology, Inc. Common Stock
STLN
$644M
-6,000
Closed -$20K
TPR icon
1450
Tapestry
TPR
$31.1B
-14
Closed -$1K

Similar funds

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.